SQL 6.6 (+0%)
US81734C1062Medical Diagnostics & ResearchDiagnostics & Research

SeqLL (SQL) Competitor Comparison

We are evaluating the key criteria listed to compare SeqLL (SQL) against its competitors in the Diagnostics & Research industry.

Linearity 3 years - SQL ranking 54 / 58

These are the competitors of SeqLL in the industry Diagnostics & Research ranked by linearity 3 years
1. Danaher DHR
111.63
2. Thermo Fisher Scientific TMO
75.51
3. Waters WAT
68.33
4. Mettler-Toledo MTD
38.87
5. IQVIA Holdings IQV
37.2
6. Agilent Technologies A
37.15
7. Ortho Clinical Diagnostics Holdings OCDX
33.4
8. Quest Diagnostics DGX
30.59
9. Laboratory Corp of America Holdings LH
19.6
10. Icon ICLR
17.08
11. PerkinElmer PKI
16.14
12. Qiagen QGEN
13.31
13. Myriad Genetics MYGN
11.12
14. Syneos Health SYNH
10.68
15. IDEXX Laboratories IDXX
7.95
16. Heska HSKA
7.67
17. Natera NTRA
7.39
18. Bioventus BVS
7.37
19. Anixa Biosciences ANIX
6.8
20. Olink Holding OLK
6.67
21. Exact Sciences EXAS
6.05
22. DexCom DXCM
4.69
23. National Research NRC
4.38
24. Sotera Health SHC
4.29
25. Global Cord Blood CO
4.22
26. Sera Prognostics SERA
3.45
27. Charles River Laboratories CRL
3.2
28. Neogen NEOG
2.66
29. Psychemedics PMD
2.63
30. MaxCyte MXCT
2.61
31. Illumina ILMN
2.57
32. Twist Bioscience TWST
2.42
33. Enzo Biochem ENZ
2.39
34. Fulgent Genetics FLGT
2.33
35. CareDx CDNA
2.26
36. Medpace Holdings MEDP
2.22
37. NeoGenomics NEO
2.18
38. MDxHealth MDXH
2.05
39. Guardant Health GH
2.03
40. Neuronetics STIM
1.98
41. Trinity Biotech TRIB
1.95
42. Co-Diagnostics CODX
1.88
43. Exagen XGN
1.86
44. Inotiv NOTV
1.79
45. Organovo Holdings ONVO
1.79
46. DarioHealth DRIO
1.79
47. bioAffinity Technologies BIAF
1.78
48. Pacific Biosciences of California PACB
1.77
49. Interpace Biosciences IDXG
1.77
50. Prenetics Global PRE
1.73
51. Biodesix BDSX
1.72
52. Precipio PRPO
1.71
53. Personalis PSNL
1.66
54. SeqLL SQL
1.48
55. Aspira Womens Health AWH
1.38
56. Meridian Bioscience VIVO
0.73
57. Lantheus Holdings LNTH
0.64
58. RadNet RDNT
0.61

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.